Please see below for the current list of Atopic Dermatitis trials being run by AvantDerm Research. If you’d like to participate, be sure to read all the details and then contact us to schedule an appointment with our research team.
ATOPIC DERMATITIS | GALDERMA RD.06.SPR.118161
PHASE III
RECRUITING
Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial for adult and adolescent subjects with moderate-to-severe atopic dermatitis (AD) and associated pruritus whose disease is not adequately controlled by topical treatments.
Randomized, double-blind, withdrawal, placebo-controlled, multi-center study investigating the use of PF-04965842 in subjects aged 12 years+ with moderate to severe atopic dermatitis.
Randomized, double-blind, placebo-controlled, parallel-group, multi-centre trial to evaluate of tralokinumab monotherapy in adolescent subjects with moderate to severe atopic dermatitis.
Randomized, double-blinded, double-dummy, placebo-controlled, parallel group, multi-centre study for PF-04965842 and Dupilumab in adults with moderate to severe atopic dermatitis.
